Dartmouth Health is the only health care system on the East Coast to be part of the newly launched Brain Health Navigator ...
Alzheimer's disease begins with a long period during which abnormal amyloid and tau proteins build up in the brain without ...
Older studies estimated a lower risk of dementia. According to new research, the number of people living with the disease in ...
Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that ...
Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...
Experts say there are ways to reduce our risk of dementia, including diet and exercise, protecting against hearing loss, and ...
Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.
Groundbreaking research reveals potential link between cytomegalovirus (CMV) and Alzheimer's disease, offering new insights ...
The Davos Alzheimer’s Collaborative (DAC), a pioneering worldwide initiative seeking to cure Alzheimer’s disease and improve ...
Activation of SIGMAR1 is expected to restore cellular homeostasis by inducing autophagy, which may slow neurodegeneration in patients with early AD.
Leqembi's subcutaneous dosing allows Alzheimer's patients to administer weekly treatment at home in 15 seconds. Get Real-Time ...